HealthLawsuits Claim GLP-1 Drugs Linked to Rare Eye Condition NAION
Patients have filed lawsuits against Novo Nordisk and Eli Lilly, alleging that their popular GLP-1 medications may cause a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION), which can lead to sudden vision loss. The claims highlight concerns about potential side effects of these widely used diabetes drugs.
News 18·2d ago




